Alternatives to LabGenius Therapeutics

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Leveraging the adaptive immune system to diagnose and treat disease.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

AI-powered drug discovery and development platform for biologics.

AI-powered platform for personalized cell therapy development and manufacturing.

Advance every cancer decision.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Biotech company focused on designing and developing novel biological solutions.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

Biotechnology company

AI-powered platform for antibody discovery and development to create new medicines.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Developing novel protein-based solutions for industrial and therapeutic applications.

Valthos is an applied biological intelligence company. We develop and deploy software and AI methods to outsmart biological evolution and ensure that these tools are deployed to safeguard humanity.

AI-powered biotech platform using protein design to discover novel therapeutic molecules for hard-to-treat targets.

Narya Bio is developing novel therapeutic antibodies for challenging diseases.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

AI-powered platform for understanding disease biology and accelerating drug discovery.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-guided drug discovery platform for tissue-targeted medicines.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Developing engineered biologics to harness the immune system for disease treatment.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Mapping cell-cell communication at scale in human tissue.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company developing next-generation gene writing tools for advanced therapies.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Biotechnology company developing novel immunotherapies for cancer.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing transformative treatments for severe genetic diseases.

Mining biological information for transformative peptide medicines.